ERIC SONG: Open Payments
NPI 1083918403 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 25 payments from 9 companies in 2025. Trend: 2023 $1,274 · 2024 $747 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $185 |
| ABBVIE INC. | 5 | $116 |
| PFIZER INC. | 3 | $61 |
| Lilly USA, LLC | 2 | $54 |
| Merz Pharmaceuticals, LLC | 1 | $32 |
| Virtus Pharmaceuticals LLC | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Electronic Waveform Lab, Inc. | 2 | $16 |
| SCILEX PHARMACEUTICALS INC. | 1 | $15 |
Products named: RELISTOR, QULIPTA, NURTEC ODT, EMGALITY, Xeomin, LEVORPHANOL TARTRATE, HYMOVIS, BOTOX.
Industry payments across CA — which companies pay providers there.
